Application 212726
- Type
- NDA
- Sponsor
- GENENTECH INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ROZLYTREK | ENTRECTINIB | CAPSULE;ORAL | 100MG | Yes | No |
| 002 | ROZLYTREK | ENTRECTINIB | CAPSULE;ORAL | 200MG | Yes | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rozlytrek | ENTRECTINIB | Genentech, Inc. | c7c71b0c-2549-4495-86b6-c2807fa54908 | 2025-12-04 | Warnings, Adverse reactions | Rozlytrek ENTRECTINIB |